Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Gsk Plc (GSK.LN)

Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Gsk Plc 79 New Oxford Street London WC1A 1DG GBR

https://www.gsk.com P: 208-047-5000

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Key Statistics

Overview:

Market Capitalization, $K 72,836,137
Shares Outstanding, K 4,037,622
Annual Sales, $ 31,376 M
Annual Net Income, $ 2,575 M
Last Quarter Sales, $ 8,547 M
Last Quarter Net Income, $ 2,013 M
% of Insider Shareholders 0.20%
% of Institutional Shareholders 56.95%

Growth:

1-Year Return 34.79%
3-Year Return 25.59%
5-Year Return 7.63%
5-Year Revenue Growth -1.45%
5-Year Earnings Growth -11.68%
5-Year Dividend Growth -9.41%

Per-Share Information:

Most Recent Earnings 0.49 on 10/29/25
Next Earnings Date N/A
Earnings Per Share ttm 1.33
EPS Growth vs. Prev Qtr 39.89%
EPS Growth vs. Prev Year 118.85%
Annual Dividend & Yield 0.63 (3.54%)
Annual Dividend & Yield (Fwd) 0.64 (3.54%)
Most Recent Dividend 0.160 on 11/13/25
Next Ex-Dividends Date 11/13/25
Dividend Payable Date 01/08/26
Dividend Payout Ratio 47.37%
Most Recent Split 4-5 on 07/19/22

GSK.LN Ratios

Ratio
Price/Earnings ttm 13.58
Price/Earnings forward 9.38
Return-on-Equity % 36.44%
Return-on-Assets % 9.20%
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales 2.32
Price/Book 4.51
Book Value/Share 4.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar